This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on August 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Initiator+ Alstra™ Microwave Peptide Synthesizer, US/JP configuration, including an Alstra trade-in
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health intends to issue a firm-fixed-price purchase order to Biotage for an Initiator+ Alstra Microwave Peptide Synthesizer in a US/JP configuration, which includes an Alstra trade-in. The government plans to solicit from a single source under the justification that only one responsible source can satisfy the agency's specific technical and functional requirements. Biotage is identified as the sole provider capable of meeting these needs due to proprietary technologies, such as its digital syringe pump reagent delivery system, robotically controlled dual-needle syringe technology, and specialized integrated software. These features are critical to maintaining the reproducibility and continuity of the government's established peptide synthesis processes, as substituting with a different manufacturer would necessitate costly and time-consuming redevelopment and revalidation of existing protocols. While this notice is not a formal request for competitive quotations, the government is inviting interested parties to submit capability statements if they believe they can meet all stated requirements. These statements must be submitted electronically to the designated point of contact no later than 9:00 a.m. EDT on August 31, 2026, referencing Notice No. 75N98026Q01052. The government will review all timely responses to determine whether to proceed with a single-source procurement or move toward a competitive process. An award is anticipated approximately five calendar days after the closing date, provided no other responsible source is identified.
General Info
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Biotage for an Initiator+ Alstra™ Microwave Peptide Synthesizer, US/JP configuration, including an Alstra trade-in.
The Government intends to solicit from a single source in accordance with FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, because the circumstances of this acquisition indicate that only one responsible source is capable of satisfying the Government's requirements.
Biotage is the only known responsible source capable of meeting the Government's specific technical and functional requirements. The Biotage Initiator+ Alstra peptide synthesizer incorporates proprietary technical capabilities that are integral to the Government's established peptide synthesis processes. These capabilities include Biotage's proprietary digital syringe pump reagent delivery system, robotically controlled dual-needle syringe technology, oscillatory mixing methodology, vacuum-pump-driven fluid transfer process, and integrated software specifically designed for the development, optimization, and execution of peptide synthesis protocols.
The Government's existing synthesis methods have been developed and validated using these proprietary features and depend upon their precise operation to maintain reproducibility, consistency, and continuity of ongoing research activities. Substitution with another manufacturer's system would require redevelopment and revalidation of established synthesis protocols and could result in significant delays, increased technical risk, potential inconsistencies in experimental results, and disruption to ongoing research activities.
Based on the Government's requirements, Biotage is the only known responsible source capable of providing a system that meets the required technical and functional requirements while maintaining compatibility with the Government's established peptide synthesis processes.
This notice is not a request for competitive quotations. However, interested sources that believe they can satisfy the Government's requirements may submit a capability statement demonstrating their ability to provide a product that meets all of the stated requirements.
The Government will consider all timely responses received and will determine whether the acquisition should proceed as a single-source procurement or be competed.
The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement.
Capability statements shall be submitted electronically to haunp@mail.nih.gov no later than 9:00 a.m. EDT on August 31, 2026.
Please reference Notice No. 75N98026Q01052 in the subject line of the response.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
